Pasithea Therapeutics Adds Esketamine Nasal Spray to its Clinic Offerings in the U.K.
Pasithea Therapeutics Adds Esketamine Nasal Spray to its Clinic Offerings in the U.K. Pasithea Therapeutics
November 23, 2021
Pasithea Therapeutics Adds Esketamine Nasal Spray to its Clinic Offerings in the U.K. Pasithea Therapeutics
Wesana Health Clinics Surpass 4,000 Administered Ketamine Treatments CHICAGO and TORONTO, Nov. 19, 2021 (GLOBE
Delic Launches Industry’s First Family Support & Education Program at Ketamine Wellness Centers (KWC) Nationwide
Silo Pharma and Strategic Partner Zylo Therapeutics Begin Development Process for Novel Ketamine Loaded Z-Pods
Pasithea Therapeutics Launches In-Home Intravenous Ketamine Therapy in Major U.S. Cities, Expanding its International Footprint
Parents Are Very Open To Ketamine Therapy For Kids, Study Finds Most parents think they
Novamind Signs LOI to Acquire Two Mental Health Clinics in Arizona TORONTO, ON / November
Awakn Life Sciences Signs MOU with NHS (Devon Partnership NHS Trust) and University of Exeter
Entheon Biomedical Announces Recruitment Underway in EBIQ-101 Clinical Study Entheon ID(TM) Clinical Study to Assess
Novamind Secures Insurance Coverage for Ketamine from Four Major Payors One of the biggest hurdles
Delic Corp Acquisition Of Ketamine Wellness Centers Is Complete Delic Completes Acquisition of Ketamine Wellness
Origin Therapeutics Portfolio Company TripSitter Expands to Eight Additional States TripSitter Clinic Corp. now offers
Ketamine rapidly improves cognitive function, making those in suicidal crisis less likely to harm themselves
MINDCURE Provides Update on Studies and Clinical Trials VANCOUVER, BC, Nov. 4, 2021 /CNW/ – Mind
Awakn Life Sciences Announces The Findings From Phase II A/B Study Are To Be Published
Braxia Scientific Graduates First Cohort of Medical Professionals From Psilocybin-Assisted Therapy Training Program; Ready to
PharmaTher Provides Research Update on Microneedle Patch Delivery Technologies for Psychedelics Completing IND-enabling studies with
Kernel’s Brain-Imaging Helmet Approved For Clinical Trial On Patients Using Ketamine An LA-based company called
MINDCURE Signs LOI with Awakn Life Sciences to Distribute Ketamine Protocol for Alcohol Use Disorder
Seelos Therapeutics Presents a Poster on SLS-002 (Intranasal Racemic Ketamine) at the 2021 IASR/AFSP International
PharmaTher Engages Alcami for Clinical and Commercial Manufacturing of Novel Ketamine Products Leading U.S.-based CDMO
Field Trip Health Ltd. Continues Expansion With Psychedelic-Assisted Therapy Centers in Seattle, Vancouver and Fredericton Field
Ketamine Wellness Centers Partners with Veterans Affairs (VA) Community Care Network to Provide Free Ketamine
PharmaTher Granted FDA Orphan Drug Designation For Ketamine To Treat Complex Regional Pain Syndrome Achieving